Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Clinical Trial Assessment of Infrastructure Matrix Tool to Improve the Quality of Research Conduct in the Community.

Dimond EP, Zon RT, Weiner BJ, St Germain D, Denicoff AM, Dempsey K, Carrigan AC, Teal RW, Good MJ, McCaskill-Stevens W, Grubbs SS, Dimond EP, Zon RT, Weiner BJ, St Germain D, Denicoff AM, Dempsey K, Carrigan AC, Teal RW, Good MJ, McCaskill-Stevens W, Grubbs SS.

J Oncol Pract. 2016 Jan;12(1):63-4, e23-35. doi: 10.1200/JOP.2015.005181. Epub 2015 Dec 1.

2.

Creating a "culture of research" in a community hospital: Strategies and tools from the National Cancer Institute Community Cancer Centers Program.

Dimond EP, St Germain D, Nacpil LM, Zaren HA, Swanson SM, Minnick C, Carrigan A, Denicoff AM, Igo KE, Acoba JD, Gonzalez MM, McCaskill-Stevens W.

Clin Trials. 2015 Jun;12(3):246-56. doi: 10.1177/1740774515571141. Epub 2015 Feb 17.

3.

Use of the National Cancer Institute Community Cancer Centers Program screening and accrual log to address cancer clinical trial accrual.

St Germain D, Denicoff AM, Dimond EP, Carrigan A, Enos RA, Gonzalez MM, Wilkinson K, Mathiason MA, Duggan B, Einolf S, McCaskill-Stevens W, Bryant DM, Thompson MA, Grubbs SS, Go RS.

J Oncol Pract. 2014 Mar;10(2):e73-80. doi: 10.1200/JOP.2013.001194. Epub 2014 Jan 14.

4.

Racial/ethnic differences in clinical trial enrollment, refusal rates, ineligibility, and reasons for decline among patients at sites in the National Cancer Institute's Community Cancer Centers Program.

Langford AT, Resnicow K, Dimond EP, Denicoff AM, Germain DS, McCaskill-Stevens W, Enos RA, Carrigan A, Wilkinson K, Go RS.

Cancer. 2014 Mar 15;120(6):877-84. doi: 10.1002/cncr.28483. Epub 2013 Dec 10.

5.

Early-phase clinical trials in the community: results from the national cancer institute community cancer centers program early-phase working group baseline assessment.

Zaren HA, Nair S, Go RS, Enos RA, Lanier KS, Thompson MA, Zhao J, Fleming DL, Leighton JC, Gribbin TE, Bryant DM, Carrigan A, Corpening JC, Csapo KA, Dimond EP, Ellison C, Gonzalez MM, Harr JL, Wilkinson K, Denicoff AM.

J Oncol Pract. 2013 Mar;9(2):e55-61. doi: 10.1200/JOP.2012.000695.

6.

Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counseling.

Jenkins J, Calzone KA, Dimond E, Liewehr DJ, Steinberg SM, Jourkiv O, Klein P, Soballe PW, Prindiville SA, Kirsch IR.

Genet Med. 2007 Aug;9(8):487-95.

PMID:
17700386
7.

Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer.

Hadley DW, Jenkins JF, Dimond E, de Carvalho M, Kirsch I, Palmer CG.

J Clin Oncol. 2004 Jan 1;22(1):39-44.

PMID:
14701766
8.

Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer.

Hadley DW, Jenkins J, Dimond E, Nakahara K, Grogan L, Liewehr DJ, Steinberg SM, Kirsch I.

Arch Intern Med. 2003 Mar 10;163(5):573-82.

PMID:
12622604
9.

The role of the nurse in cancer genetics.

Middelton L, Dimond E, Calzone K, Davis J, Jenkins J.

Cancer Nurs. 2002 Jun;25(3):196-206. Review.

PMID:
12040228

Supplemental Content

Loading ...
Support Center